Clinical Trial Update: NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single Inhaler

View source ↗

Summary

This document reports the completion of a non-interventional study evaluating the use of Symbicort Turbuhaler as maintenance and reliever therapy in a single in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort Turbuhaler (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED